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A B S T R A C T
Cobalamin deficiency is associated with a wide spectrum of hematologic, neurologic, gastroenterologic and psychiat-
ric disorders or symptoms. We report a case of a 50-year-old man with complex partial seizures with secondary general-
ization, mood oscillations and psychotic symptoms alternating with confusion and reversible dementia secondary to
cobalamin deficiency in the absence of typical neurologic and/or hematologic symptoms and signs. Exclusion of epilepsy,
acute, atrophic or expansive lesion of central nervous system and usual etiology associated with reversible dementia (in-
fectious diseases, an endocrine etiology and deficiency of vitamins other than cobalamin); finding of cobalamin defi-
ciency only and complete neuropsychiatric recovery after substitution, confirmed etiology. Typical and atypical psychiat-
ric manifestations due to cobalamin deficiency that precede neurologic and/or hematologic signs and symptoms can
recover completely after adequate replacement therapy.
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Introduction
Cobalamin deficiency has long been associated with a
wide spectrum of hematologic, neurologic, gastroente-
rologic and psychiatric disorders or symptoms. Anemia
and macrocytosis are the most frequent hematologic
manifestation, while combined medullar sclerosis toge-
ther with peripheral sensory neuropathies is the most
common neurologic manifestation of cobalamin deficien-
cy1-3. A wide spectrum of psychiatrically inclined disor-
ders or symptoms have been documented to be associated
with cobalamin deficiency. Slow cerebration, confusion,
memory disturbances, delirium with or without halluci-
nations and/or delusions, depression and acute psychotic
states are frequently seen, while reversible manic and
schizophreniform states rather rarely4-9.
Psychiatric manifestations due to cobalamin deficien-
cy commonly precede neurologic symptoms and/or mega-
loblastic anemia. The importance of such finding is in the
potential for early substitution interventions in patients
with psychiatric symptoms due to cobalamin deficiency,
but without anemia, macrocytosis or spinal cord symp-
toms.
Case Report
A 50-year-old male patient presented with seizures,
mood oscillations associated with psychotic symptoms
(delusions of different type, most prominently paranoid
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and auditory hallucinations) and reversible dementia.
He had no previous psychiatric or neurological treat-
ment; somatically healthy.
No typical hematologic or traditional neurologic re-
percussions due to cobalamin deficiency (anemia, macro-
cytosis, combined medullar sclerosis together with peri-
pheral sensory neuropathies) were found. Folate level was
normal. Different known causes associated with revers-
ible dementia (infectious diseases, endocrine etiology, defi-
ciency of vitamins other than cobalamin) were excluded.
Repeated: glycemia, blood analysis (biochemistry, he-
matology), thyroid function, urine analysis, electrolytes,
erythrocyte sedimentation rate, C-reactive protein val-
ues and cerebrospinal fluid findings were normal. No pa-
rameters of infectious diseases were found. All serology
results (including testing to Borrelia burgdorferi, impor-
tant because of patient’s profession: forestry worker)
were normal. Tumor markers were normal. Endocrine
etiology and deficiency of vitamins other than cobalamin
were excluded as causes of reversible dementia. Per-
formed ECG records, X-ray of the lungs, repeated inter-
nistic and infectologic examinations were normal. Fun-
doscopy showed normal findings.
Repeated EEG records, performed after seizures and
within inter-seizures periods, showed discretely irregu-
lar, but normal findings. Repeated NMR findings (three
within two–months’ period, all normal) excluded acute
and/or expansive CNS lesion, as well as cerebral atrophy
inadequate for patient’s age.
The first neuropsychiatric manifestations due to co-
balamin deficiency included three seizurs, periods of con-
fusion alternating with periods of almost normal func-
tioning with coexisting: mood oscillations and psychotic
symptoms and reversible dementia. All seizures were of
complex partial type with secondary generalization. Pa-
tient’s mood oscillated between depression, euthymia,
dysphoria and emotional lability, while the most promi-
nent psychotic features included paranoid delusions
(within a wide spectrum of various delusions) and audi-
tory hallucinations. Sleep disturbances (initial and mid-
dle insomnia) were part of the clinical picture, too. Final-
ly, reversible dementia was observed with the lowest
Mini Mental State Examination (MMSE)10 sum of 16.
During initial four-months’ treatment period, a com-
bination of psychopharmacotherapy (haloperidol 2 mg/
daily, diazepam 15 mg/daily and carbamazepine 800 mg/
daily) and cobalamin substitution was chosen. Cobala-
min replacement therapy had the following scheme: Hy-
droxycobalamin 1000 ng/day i.m. for 10 days, followed
with 1000 ng/once weekly i.m. for next 6 weeks, and, fi-
nally, 1000 ng i.m. once monthly and still ongoing. After
initial four–months’ combined (substitution and psycho-
pharmacs) therapy, only partial neuropsychiatric recov-
ery was achieved. Sleep disturbances were reduced, sei-
zures disappeared, periods of confusion became less fre-
quent, though still present, while periods with coexisting
mood oscillations and psychotic symptoms were signifi-
cantly shortened. Hallucinations disappeared, as did most
of delusions, with the exception of paranoid delusions
that persisted, but with a much lower intensity. At the
end of the initial four–months’ treatment period, the
MMSE was an average of 22.
During the next four months, the patient was on re-
placement therapy only (patient’s decision), receiving
hydroxycobalamin 1000 ng/monthly i.m. and complete
neuropsychiatric recovery was achieved. No confusion,
seizures, mood oscillations, psychotic symptoms or cogni-
tive impairments (MMSE sum was 30!) were found. Pa-
tient achieved full clinical remission.
Presently, after a one-year follow up, patient is still
receiving hydroxycobalamin 1000 ng/once monthly i.m.
and is still in complete clinical remission.
Discussion
Cobalamin deficiency is not a rare finding. Typical
clinical triade includes: megaloblastic anemia, glossitis
and neuropsychiatric symptoms1-3.
In our case, in relatively young patient (without ear-
lier internistic, neurologic and/or psychiatric complaints)
cobalamin deficiency manifested itself with atypical neu-
ropsychiatric triade: seizures, confusion periods alter-
nating with episodes with coexisting mood oscillations
and psychotic symptoms (delusions of various type, most
prominently paranoid and auditory hallucinations) and
reversible dementia (MMSE sum increased from 16 to 30
after replacement therapy).
After the initial four-month combined pharmacothe-
rapy (small dose of haloperidol in combination with diaz-
epam and carbamazepine) and cobalamin substitution,
only partial therapeutic result was achieved. Seizures
disappeared, periods of confusion became less frequent
but still present, alternating with periods of less ex-
pressed mood oscillations and reduced, but still present,
psychotic component: paranoid delusions, while sleep
disturbances were partially relieved. An attempt was
made to increase the dose of haloperidol, during a three
weeks’ period, to 4-6 mg/daily (with diazepam 15 mg/day
and carbamazepine 800 mg/day, constantly), but no clini-
cally significant improvement was achieved, while the
patient reacted with mild extrapyramidal symptoms,
which withdrew completely after dosage reduction. Sub-
sequently, during a one-week period risperidon up to 4
mg/daily was prescribed to substitute haloperidol (com-
ponent of combined pharmacotherapy – with diazepam
and carbamazepine), but worsening of psychiatric status
ensued. Delusions and confusion periods were more fre-
quent and patient and his family insisted on returning to
a small dose of haloperidol. During the second four-
-month treatment period, patient received cobalamin
substitution only, at the end of which complete neuropsy-
chiatric recovery was achieved. Seizures, confusion, mood
oscillations, psychotic symptoms and cognitive impair-
ments disappeared.
We speculate that patient developed cobalamin defi-
ciency most probably due to decreased absorption. There
was no previous inadequate dietary intake due to psychi-
atric problems or other reasons that could result in de-
creased serum cobalamin level.
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Discovering of potentially reversible cause of cogni-
tive impairments or even dementia (in our case, associ-
ated with seizures, mood oscillations, psychotic symptoms
and sleeping disturbances), such as cobalamin deficiency,
does not always mean that after adequate replacement
therapy the patient will recover completely. In many
cases, for only partial recovery, a combination of psycho-
pharmacs and substitution therapy is needed. Still, com-
plete recovery is possible. In our case, after an initial
combination of psychopharmacotherapy and vitamin re-
placement, only partial recovery was observed, while af-
ter a continued cobalamin replacement therapy only, full
neuropsychiatric recovery was achieved. In each single
case, an individual treatment strategy should be chosen,
always counting with the possibility of complete clinical
remission after adequate replacement therapy.
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DEFICIT KOBALAMINA MANIFESTIRAN KONVULZIJAMA, OSCILACIJAMA RASPOLO@ENJA,
PSIHOTI^NIM ELEMENTIMA I REVERZIBILNOM DEMENCIJOM U ODSUSTVU TIPI^NIH
NEUROLO[KIH I HEMATOLO[KIH ZNAKOVA I SIMPTOMA: PRIKAZ SLU^AJA
S A @ E T A K
Deficit kobalamina je povezan sa {irokim spektrom hematolo{kih, neurolo{kih, gastroenterolo{kih i psihijatrijskih
poreme}aja i simptoma. Prikazan je slu~aj 50-godi{njeg mu{karca s krizama svijesti (kompleksne parcijalne sa sekun-
darnom generalizacijom), oscilacijama raspolo`enja i psihoti~nim simptomima koji su se izmjenjivali sa smeteno{}u i
reverzibilnom demencijom kao manifestacijama deficita kobalamina, a u odsutnosti tipi~nih neurolo{kih i/ili hema-
tolo{kih simptoma i znakova. Etiologija je potvr|ena isklju~enjem epilepsije, akutne, atrofi~ne ili ekspanzivne lezije
sredi{njeg `iv~anog sustava i drugih poreme}aja povezanih s reverzibilnom demencijom (infektivne bolesti, endokrina
etiologija i deficiti ostalih vitamina), te na|enim izoliranim deficitom kobalamina i potpunim povla~enjem neuropsi-
hijatrijskih simptoma nakon nadoknade kobalamina. Tipi~ne i atipi~ne psihijatrijske manifestacije deficita kobalamina
koje mogu prethoditi neurolo{kim i/ili hematolo{kim znakovima i simptomima, mogu se u potpunosti povu}i nakon
adekvatne nadomjesne terapije.
